Locally advanced
squamous cell carcinoma of the head and neck is commonly treated with
chemoradiotherapy (CRT).
It remains
uncertain if residual adenopathy (RA), greater than 1 cm in maximal
dimension, detected by computerized tomography following treatment has an
impact on outcome.
Similarly, the
utility of neck dissection (ND) to pathologically evaluate RA remains undefined.
We performed a retrospective analysis to assess the frequency and impact of RA
and the utility of ND in SCCHN.
No comments:
Post a Comment